In particular, we demonstrated that TEVs released by IL-1β-stimulated EGFR mutant NSCLC cells are enriched with fibronectin, similarly to the ones released from the EGFR-resistant model PC9/OR. The gene discussed is FN1; the disease is non-small cell lung carcinoma.